Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Explantation of durable ventricular assist device for myocardial functional recovery in children: A report from the ACTION registry.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Prospective Multicenter Evaluation of a Novel Active Driving System for Pediatric Ventricular Assist Device Support.

Journal of the American College of Cardiology·2026
Same author

Multicenter Registry Analysis of Bivalirudin for Primary Anticoagulation in Pediatric HeartMate 3 Recipients: ACTION Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Capturing Physiological Data in Children With Heart Failure Using Wearable Digital Technology: Lessons From Pilot Project.

CJC pediatric and congenital heart disease·2026
Same author

Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era.

Pediatric transplantation·2025
Same author

Authors Insights on the Updated International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014).

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
查看所有相关文章

相关实验视频

Updated: Jul 15, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

持久的机械循环支持:JACC科学声明

Ryan J Tedford1, Marzia Leacche2, Angela Lorts3

  • 1Medical University of South Carolina, Charleston, South Carolina, USA.

Journal of the American College of Cardiology
|September 27, 2023
PubMed
概括
此摘要是机器生成的。

耐用左心室辅助器件 (dLVADs) 为晚期心力衰竭患者提供了更好的生存率,在5年内接近60%. 然而,诸如推迟转诊等挑战阻碍了这一关键疗法的更广泛采用.

关键词:
心脏衰竭是因为心脏衰竭.心脏移植心脏移植手术左心室辅助装置的使用机械循环支持 机械循环支持

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K

相关实验视频

Last Updated: Jul 15, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K

科学领域:

  • 心脏病学 心脏病学
  • 医疗器械 医疗器械
  • 心脏衰竭管理的管理

背景情况:

  • 晚期心力衰竭 (HF) 仅仅通过医疗治疗就有不良预后.
  • 耐用左心室辅助装置 (dLVAD) 是高级高频率患者的关键选择.
  • 最近的dLVAD创新已经改善了安全性和患者存活率.

研究的目的:

  • 审查与dLVAD治疗相关的当代结果和挑战.
  • 突出dLVADs作为桥梁移植或目的地治疗的潜力.
  • 讨论新兴的dLVAD技术.

主要方法:

  • 关于dLVAD技术和患者结果的当前文献的综述.
  • 对生存率和不良事件概况的分析.
  • 讨论临床采用障碍和未来的设备开发.

主要成果:

  • dLVAD的支持显示,5年生存率接近60%,相当于心脏移植2年.
  • 随着技术的进步,血栓,中风和出血等不良事件已经减少.
  • 采用dLVAD的重大障碍包括患者推迟转诊以及临床医生对结果和生活质量益处的认识不足.

结论:

  • 对于晚期心力衰竭患者,dLVAD疗法提供了显著的生存益处.
  • 解决转诊障碍和提高临床医生的知识对于更广泛的dLVAD采用至关重要.
  • 新的,不那么侵入性的dLVAD技术正在开发中,有望进一步改进.